Barings Corporate Investors (NYSE:MCI – Get Free Report) was the recipient of a large growth in short interest during the month of August. As of August 31st, there was short interest totaling 66,525 shares, a growth of 384.1% from the August 15th total of 13,743 shares. Based on an average daily volume of 74,387 shares, the short-interest ratio is currently 0.9 days. Currently, 0.3% of the shares of the stock are sold short.
Barings Corporate Investors Price Performance
Barings Corporate Investors stock traded up $0.49 during trading hours on Friday, hitting $19.77. 91,026 shares of the stock were exchanged, compared to its average volume of 38,657. Barings Corporate Investors has a 12 month low of $16.21 and a 12 month high of $23.00. The business’s 50-day moving average is $17.55 and its two-hundred day moving average is $17.93.
Barings Corporate Investors Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be given a $0.40 dividend. The ex-dividend date is Friday, August 28th. This represents a $1.60 annualized dividend and a yield of 8.1%.
Institutional Trading of Barings Corporate Investors
Barings Corporate Investors Company Profile
Barings Corporate Investors (NYSE: MCI) is a closed-end management investment company that seeks to provide investors with high current income and capital preservation. The fund primarily invests in a diversified portfolio of corporate debt securities and loans, focusing on investment-grade and below investment-grade credit issued by U.S. and international companies.
The fund’s investment strategy centers on identifying opportunities across the corporate credit spectrum, including senior secured loans, high-yield bonds, and other fixed-income instruments.
Recommended Stories
- Five stocks we like better than Barings Corporate Investors
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
- Oracle’s AI Spending Is Still Huge, But the Payoff Is Starting to Show in Earnings
Receive News & Ratings for Barings Corporate Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Barings Corporate Investors and related companies with MarketBeat.com's FREE daily email newsletter.
